SCHEMBL9404972

SCHEMBL9404972

CCNCCc1ccc(OC(=O)c2cccnc2)c(OC(=O)c2cccnc2)c1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.57
HSD17B10 Q99714 1/20 0.52
KMT2A Q03164 7/20 0.50
LMNA P02545 2/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSP90AA1 P07900 2/20 0.45
AGTR1 P30556 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
CCR6 P51684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9404946 0.92 MAPK1 (0.56) MAPK1HSD17B10KMT2ALMNAALDH1A1
SCHEMBL9404860 0.85 ADRB2 (0.55) KMT2AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL9404951 0.85 MAPK1 (0.56) MAPK1HSD17B10KMT2ALMNAALDH1A1
SCHEMBL9404933 0.84 ADRB2 (0.43) MAPK1KMT2AALDH1A1L3MBTL1
SCHEMBL9404867 0.84 PKM (0.60) MAPK1KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL9404871 0.82 KMT2A (0.52) MAPK1HSD17B10KMT2ALMNAALDH1A1
Hydrochloric Acid SCHEMBL9404915 0.81 KMT2A (0.51) MAPK1HSD17B10KMT2ALMNAALDH1A1
SCHEMBL9404862 0.79 ADRB2 (0.56) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL9011269 0.78 MAPK1 (0.76) MAPK1KMT2ALMNACYP1A2NPC1
SCHEMBL9404877 0.78 NPC1 (0.47) MAPK1KMT2ALMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0431942-B1 Percutaneously absorbable pharmaceutical preparation containing dopamine derivative SANSHO CO (JP) 1994-03-23 EP disclosed
US-5246949-A And lactic acid esters, treatment of hypotension and cardiac circulatory insufficiency SANSHO CO., LTD. (JP) 1993-09-21 US disclosed
EP-0431942-A2 Percutaneously absorbable pharmaceutical preparation containing dopamine derivative SANSHO CO., LTD. (JP) 1991-06-12 EP disclosed